Articles in PresS. Am J Physiol Endocrinol Metab (June 10, 2008). doi:10.1152/ajpendo.90397.2008
1 Relationships between Exercise-Induced Reductions in Thigh Intermuscular Adipose Tissue, Changes in Lipoprotein Particle Size, and Visceral Adiposity Michael T. Durheim1, Cris A. Slentz2, Lori A. Bateman2, Stephanie K. Mabe2, and William E. Kraus2,3
Author Affiliations: From the 1School of Medicine, 2Division of Cardiovascular Medicine, Department of Medicine, and 3Duke Center for Living, Duke University Medical Center, Durham, NC.
Running Head: Exercise, Intermuscular Fat and Lipoprotein Changes
Address for Correspondence: Michael T. Durheim Box 102903, Duke University Medical Center 1300 Morreene Road Durham, NC 27705
[email protected] Phone: 919-660-6786 Fax: 919-668-3697
Copyright © 2008 by the American Physiological Society.
2 ABSTRACT Small LDL and HDL particle size are characteristic of a pro-atherogenic lipoprotein profile. Aerobic exercise increases these particle sizes. While visceral adipose tissue (VAT) has been strongly linked with dyslipidemia, the importance of intermuscular adipose tissue (IMAT) to dyslipidemia and exercise responses is less well understood. We measured exerciseassociated changes in thigh IMAT and VAT, and examined their relationships with changes in LDL and HDL particle size. Sedentary, dyslipidemic, overweight subjects (n = 73) completed 8 to 9 months of aerobic training. Linear regression models were used to compare the power of IMAT change and VAT change to predict lipoprotein size changes. In men alone (n = 40), IMAT change correlated inversely with both HDL size change (r = -0.42, P = 0.007) and LDL size change (r = -0.52, P < 0.001). That is, reduction of IMAT was associated with a shift toward larger, less atherogenic lipoprotein particles. No significant correlations were observed in women. After adding VAT change to the model, IMAT change was the only significant predictor of either HDL size change (P = 0.034 for IMAT vs. 0.162 for VAT) or LDL size change (P = 0.004 for IMAT vs. 0.189 for VAT) in men. In conclusion, in overweight dyslipidemic men, exercise-associated change in thigh IMAT was inversely correlated with both HDL and LDL size change, and was more predictive of these lipoprotein changes than was change in VAT. Reducing IMAT through aerobic exercise may be functionally related to some improvements in atherogenic dyslipidemia in men. KEYWORDS: aerobic training, visceral fat, adipose tissue, HDL size, LDL size.
3 INTRODUCTION Small LDL and HDL particle size are components of atherogenic dyslipidemia (2, 17, 22, 34), which is an established risk factor for cardiovascular disease (CVD). Aerobic exercise increases the average diameter of both of these particles (10, 15), resulting in a less atherogenic lipoprotein profile. Less is known, however, about the mechanisms by which exercise mediates these improvements. The effects of regional fat distribution on atherogenic dyslipidemia have been well characterized, with increased visceral adiposity being associated with less favorable lipoprotein profiles (3, 18, 19, 22, 25). Visceral adipose tissue (VAT) has been described as an “ectopic” adipose depot associated with impaired fat oxidation and loss of the normal ability to store excess energy as subcutaneous fat (11). In contrast, relationships between lipoprotein profiles and thigh intermuscular adipose tissue (IMAT), which might be viewed as a peripheral ectopic fat depot, have not been widely studied. IMAT lies within the fascia lata surrounding the leg musculature—thus distinguishing it from subcutaneous adipose tissue in the leg—and surrounds and infiltrates muscle groups, with which it shares a direct vascular connection. This anatomical relationship is analogous to that of visceral fat and the liver in the abdomen, suggesting that IMAT might have a functional influence on skeletal muscle metabolism analogous to that of VAT on liver metabolism. The Studies of a Targeted Risk Reduction Intervention through Defined Exercise (STRRIDE) trial (16) was designed to compare the effects of differing amounts and intensities of aerobic exercise on plasma lipoproteins and other metabolic risk factors. The primary analysis of lipoprotein changes has been reported previously (15), and demonstrated graded improvements in LDL and HDL particle size with increasing exercise volume. Given the higher
4 requirement of skeletal muscle for oxidative fuel at higher amounts of exercise, and the close anatomical connection between IMAT and skeletal muscle, we hypothesized that IMAT is a readily mobilized source of lipid fuel, and thus that exercise-induced change in IMAT would be associated with concurrent changes in particle sizes reflective of a more favorable lipoprotein profile. The objective of the present analysis was to determine the association between changes in thigh IMAT and in HDL and LDL particle size in the context of an aerobic exercise intervention, and to compare the power of IMAT and VAT changes to predict these lipoprotein changes.
5 METHODS A detailed description of the STRRIDE study design has been published elsewhere (16). The institutional review board at Duke University reviewed and approved the study protocol, and informed consent was obtained from all subjects. Subjects. Subjects were 40-65 years old, previously sedentary, overweight or class I obese (BMI 25-35 kg/m2), and met at least one of two criteria for dyslipidemia: (a) fasting LDL of 130-190 mg/dL and/or (b) fasting HDL less than 40 mg/dL for men or 45 mg/dL for women. The study included subjects self-classified as Caucasian, African-American, and other (e.g. Hispanic and Asian) races. Subjects were randomly assigned to one of three exercise training groups or an inactive control group that did not change physical activity habits. Subjects were recruited continuously from Durham, NC and surrounding areas between January 1999 and June 2002. All exercise training was completed by April 2003. Since the objective was to study exercise-induced changes in IMAT, all exercise-exposed subjects with complete lipid data and mid-thigh CT scans obtained both before and after the training period (n = 73) were included in the present analysis, with control subjects excluded. Exercise training. The three exercise training groups were defined as follows: (1) High amount/vigorous intensity, 23 kcal/kg/week at 65-80% peak VO2; (2) Low amount/vigorous intensity, 14 kcal/kg/week at 65-80% peak VO2; (3) Low amount/moderate intensity, 14 kcal/kg/week at 40-55% peak VO2. These regimens are calorically equivalent to approximately 20 miles/week of jogging, 12 miles/week of jogging, and 12 miles/week of brisk walking for a 90 kg person, respectively. Subjects exercised for a two to three month ramp period followed by six months at one of the above prescriptions, for a total of eight to nine months of exercise
6 training. All exercise sessions were verified by recorded data from heart rate monitors (Polar Electro, Inc.; Woodbury, NY). Lipoprotein measurements. Fasting plasma samples were analyzed by LipoScience, Inc. (Raleigh, NC) using nuclear magnetic resonance spectroscopy, as previously described (15, 21). The concentrations of four LDL and five HDL subclasses were measured, and the weighted average sizes of LDL and HDL calculated. Adipose tissue measurements. Thigh and abdominal CT scans were obtained before and after the training period, using a General Electric CT/I (GE Medical Systems, Milwaukee, WI). With subjects in the supine position, a single 10mm axial section was obtained from the midpoint of the left thigh (midway between the acetabulum and the patella), and from the abdomen at the level of the L4 pedicle. Exact locations for these sections were determined from digital frontal scout radiographs. Images were analyzed using Slice-O-Matic 4.3 software (Tomovision, Montreal, Quebec, Canada). For the thigh, the fascia lata was traced manually to distinguish subcutaneous from intermuscular adipose tissue. Intermuscular adipose tissue area was defined as all tissue within the attenuation range -190 to -30 Hounsfield units (9) lying deep to the fascia lata (5, 36). Visceral adipose tissue area was defined as all tissue in the same attenuation range lying within the abdominal cavity. Data analysis. Change scores for IMAT area, VAT area, and lipoprotein particle sizes were calculated by subtracting the pre- from the post-training value. Univariable relationships were tested with Pearson correlations. Multivariable relationships were tested using general linear models without selection; that is, we forced all of our explanatory variables of interest into the models. To address the possibility that associations differed by gender, our initial models included a gender*IMAT change interaction term. When this interaction term was significant,
7 subsequent analyses were performed separately by gender. Models were validated on 1000 bootstrap replicates of the sample to assess the stability of the observations. These replicates were generated with SAS 9.1 (Cary, NC); all other statistical analysis was performed with SAS Enterprise Guide 4.1 (Cary, NC). The threshold for statistical significance was set a priori at P < 0.05. Variables that were not normally distributed were log-transformed prior to statistical analysis. Except where noted, descriptive data are presented as mean ± standard deviation (S.D.) for continuous variables, and frequency (%) for categorical variables.
8 RESULTS Subject Characteristics Subject characteristics are presented in Table 1. There were no gender differences in baseline BMI serum triglycerides, fasting glucose, or fasting insulin. There were similar proportions of Caucasians, African-Americans, and subjects of other races among men and women. Exercise group allocation was similar between genders, and men and women were similarly adherent to their exercise prescriptions (all P > 0.05). Men were slightly younger, had higher body mass and higher peak oxygen consumption at baseline, whereas women were more insulin-sensitive. Men had lower HDL and LDL levels, and smaller HDL and LDL sizes. Men also had more visceral adipose tissue, but less intermuscular and subcutaneous adipose tissue in the thigh than women (all P < 0.05). Changes in subject characteristics are also summarized in Table 1. Men had greater decreases in body mass, BMI, and VAT, and a greater improvement in fitness with exercise training. Thigh IMAT and thigh SAT decreased significantly with exercise in both men and women, but these changes did not differ by gender. Men had within-gender improvements in insulin sensitivity and triglycerides, whereas women improved fasting insulin. Gender Effects We first tested the association between exercise-induced change in IMAT and change in LDL and HDL particle sizes. We hypothesized that loss of IMAT would be associated with increases in these particle sizes, implying an improvement in metabolic state. Given known gender differences in regional fat distribution, we included gender and IMAT in the linear regression model. While gender itself did not affect particle size change with exercise training (Table 2, P = 0.87 and 0.70 for HDL and LDL, respectively), the interaction term gender*IMAT
9 change was significant for both HDL and LDL size change (P = 0.02 and 0.01, respectively). This indicated that the association between IMAT change and particle size change differed between men and women. Univariable Relationship Between IMAT Change and Particle Size Change Given this finding, we evaluated the relationship between IMAT change and lipoprotein particle size change separately for each gender. In men, IMAT change was negatively correlated with change in both HDL size (r = -0.42, P = 0.0065) and LDL size (r = -0.52, P = 0.0006), as shown in Fig. 1. That is, loss of IMAT was associated with increases in size for both HDL and LDL particles in men. In contrast, there was no relationship between IMAT change and change in either HDL size (P= 0.87) or LDL size (P = 0.92) in women. Given the close functional relationship between VLDL, HDL, and LDL particle sizes, VLDL size change might be expected to have the converse relationship with IMAT change in men, and this indeed was observed in our study (r = 0.33, P = 0.0359). In 1000 bootstrap replicates of the sample, performed to assess the stability of the finding across repeated assessments, the mean ± S.D. Pearson correlation coefficient was -0.53 ± 0.10 for LDL size change in men, and the model was significant at P < 0.05 in 987 (98.7%) of the 1000 replicates. For HDL size change in men, the mean correlation coefficient was -0.43 ± 0.10, and the model was significant in 892 (89.2%) of the 1000 replicates. Comparing the Effects of IMAT Change and VAT Change We compared the power of exercise-induced changes in IMAT and VAT to predict lipoprotein size change in men. When VAT change and IMAT change were both included in the multivariable model, IMAT change remained independently associated with HDL size change (P=0.0343, Table 3), while VAT change did not (P = 0.16). IMAT change likewise remained
10 independently associated with LDL size change in a multivariable model (P = 0.0042), while ΔVAT did not (P=0.19). We then repeated the full fitted models on 1000 bootstrap replicates of the sample to assess the stability of the observations. IMAT change was independently associated with change in HDL size in 593 (59.3%) of 1000 bootstrap replicates, compared with 245 (24.5%) for VAT change. IMAT change was independently associated with change in LDL size in 921 (92.1%) of 1000 bootstrap replicates, compared with 282 (28.2%) for VAT change.
11 DISCUSSION Atherogenic dyslipidemia is related to a range of genetic, metabolic, and body compositional characteristics. While weight loss and reductions in adiposity are well known to improve the lipoprotein profile, the primary objective of the current study was to investigate the relationship between improvements in lipoprotein particle size and exercise-induced changes in thigh intermuscular adipose tissue (IMAT), which has recently attracted increasing interest as an ectopic fat depot. We also aimed to compare IMAT to visceral adipose tissue (VAT), a more established ectopic fat depot, in this context. We observed that exercise-induced reductions in IMAT were associated with favorable increases in lipoprotein particle size in sedentary, overweight to mildly obese dyslipidemic men. We also observed that IMAT change remained independently associated with both HDL and LDL size change in men after controlling for the effects of VAT change. VAT change was not independently predictive in these models. No associations between IMAT change and particle size changes were observed in women. There have been relatively few reports of relationships between changes in regional adipose depots and concurrent changes in CVD risk factors in the context of aerobic exercise. Our group has previously reported on decreases in VAT in the STRRIDE trial (29), and found that these decreases were associated with decreases in LDL particle number, while negative correlations between VAT change and both LDL and HDL size approached statistical significance (P = 0.052 and 0.057, respectively). Janssen et al. (13) failed to observe associations in obese women between reductions in VAT—by diet or diet plus exercise—and any metabolic variable, including serum triglyceride, LDL, and HDL concentrations.
12 In cross-sectional studies, high intermuscular adiposity in the thigh has been associated with elevated total cholesterol and fasting glucose (36), impaired glucose tolerance and type 2 diabetes (8), and metabolic syndrome (7). However, it does not necessarily follow that modifying fat distribution will, in turn, modify these metabolic factors. Cross-sectional body composition relationships are likely to be multifactorial in origin and, while providing descriptive information on high-risk metabolic states, may not inform our view of how those risks can be modified. To our knowledge, previous comparisons of the relative importance of IMAT and VAT to metabolic risk variables have been exclusively cross-sectional. Yim et al. (36) reported that IMAT was more strongly associated than VAT with total cholesterol and fasting glucose. In nondiabetic women, higher IMAT content is associated with low insulin sensitivity index, independent of visceral adiposity and body weight (1). In contrast to these studies, a randomized controlled trial of aerobic exercise interventions enabled us to investigate the relative importance of exercise-induced changes in IMAT and VAT to the mechanism of concurrent improvement in components of the lipoprotein profile. Reductions in IMAT were more strongly associated with improved lipoprotein particle sizes than reductions in VAT, suggesting that IMAT changes rival or even predominate over VAT changes as possible mediators of exercise-induced improvements in some components of atherogenic dyslipidemia. Thus the observed association between IMAT change and changes in lipoprotein particle size may advance our understanding of the mechanisms by which aerobic exercise mitigates atherogenic dyslipidemia. The definitive mechanistic link between IMAT and lipoprotein particle size remains to be determined. IMAT in the thigh is closely apposed to the skeletal muscle, which is directly
13 targeted by aerobic exercise training. As the energy demands of the muscle increase with training, it is reasonable to expect that this adipose depot would serve as a ready source of free fatty acids for oxidation. Indeed, our group has previously shown that increases in lipoprotein particle size are associated in a dose-response manner with the volume (weekly caloric expenditure) of aerobic training regimens (15). It is possible that IMAT, as a putative ectopic fat depot, is preferentially mobilized as fuel and thus serves as a quantifiable marker of this relationship. The anatomic position of IMAT—within the myofascial compartment and with direct vascular connection to more metabolically active tissues—is analogous to that of VAT in the abdomen, with its direct vascular link to the liver. Although this characteristic of IMAT does not differ by gender, and thus does not explain why we observed relationships between IMAT and metabolic state in men but not in women, it should be noted that such sexually dimorphic relationships are not without precedent: in the STRRIDE cohort, associations between VAT and lipoprotein particle size and other metabolic variables were stronger in women (35), in direct opposition to the current observation in the peripheral limb. Exercise-induced changes in lipoprotein lipase (LPL) activity may underlie the observed gender difference in the strength of the relationship between changes in IMAT and metabolic state. LPL acts locally at the vascular endothelium to cleave triglyceride from lipoproteins, thus allowing its incorporation into the nearby tissue for use as fuel (in skeletal muscle) or for storage (in adipose tissue). This results in larger lipoprotein particles, as the triglyceride is replaced by cholesterol esters. Indeed, serum LPL levels are positively correlated with both HDL and LDL size in cross-sectional analyses (26). One recent study reported that the oral hypoglycemic agent metformin increased both LPL activity and LDL size, and that these changes were significantly correlated (20). The peroxisome proliferator-activated receptor (PPAR) activator troglitazone
14 similarly increases both LDL size and LPL activity (30). Gender differences in LPL action have been inconsistently observed. In some cross-sectional analyses, overall LPL activity is higher in women (4, 6), while another report did not observe gender differences in LPL protein levels (32). Muscle-specific LPL activity does not differ by gender in either untrained or endurance-trained subjects (14). Following 5 to 13 days of exercise in men, LPL mRNA expression and enzyme activity increase in skeletal muscle, but not in adipose tissue (27), though the mRNA increase is transient (28). At least one study (23) suggests that muscle-associated LPL activity increases acutely in men, but not women, following aerobic exercise. Adipose tissue-associated LPL activity also increases in men, though to a lesser extent than in muscle, and decreases slightly in women under the same conditions. The HERITAGE family study showed a significantly greater increase in LPL activity in white men compared to women following 20 weeks of exercise (6), while others have found no change in LPL protein level for either gender following six months of training (32). LPL activity decreases to a greater degree in IMAT compared with other adipose depots, and in male compared with female guinea pigs exposed to exercise training (24). Thus the effects of exercise on regulation of LPL activity differ by tissue and perhaps gender. If muscle LPL activity increased, and IMAT LPL activity decreased, in the context of increased fatty acid oxidation with aerobic training, we might expect mobilization of thigh IMAT as fuel to increase. If these LPL activity changes were more prominent in men than women, IMAT loss would therefore be correlated with lipoprotein particle size increases in the gender-specific manner observed in this study. Exercise likely affects lipoprotein particle size via hepatic mechanisms in addition to peripheral lipid oxidation (31). Specifically, higher hepatic lipase (HL) activity is associated with a higher ratio of (small) HDL3 to (large) HDL2 (4), and aerobic training decreases HL
15 activity (33). Thompson et al. observed that in men, but not women, HL levels decrease and HDL2 concentrations increase following six months of training, while HDL3 levels do not change significantly (32). Nonetheless, our data suggest that exercise-induced improvements in HDL and LDL size are partially driven by changes in peripheral skeletal muscle and fat metabolism. Further investigation is necessary to identify in greater detail the physiologic mechanisms linking reduction of IMAT to increases in lipoprotein particle size. The results of the current analysis will help generate hypotheses for further study. At minimum, lifestyle intervention studies of this type may help differentiate putative risk factors and markers that are modifiable and drive changes in CVD risk from those that are only cross-sectionally related. Strengths While regional fat distribution has been shown to correlate with many markers of cardiovascular risk in cross-sectional analyses, the present study design afforded the opportunity to determine the relationship between changes in fat stores and changes in these risk factors. Thus, while we do not yet comprehensively understand the mechanisms of exercise-induced improvements in lipoprotein profile, our data do help to generate hypotheses for investigating these causal pathways. In addition, our subjects maintained a constant diet and body weight throughout the study, allowing us to examine the effects of aerobic exercise in isolation. Limitations The present analysis had a relatively low sample size, which did not confer sufficient power to determine the effect of different exercise training regimens on changes in thigh fat distribution. Such data would have been informative in light of previously reported differences in particle size improvements among exercise groups differing in amount and intensity in the STRRIDE trial (15). We also lacked a three-dimensional measure of regional adiposity, which
16 might have proven more precise than single-slice CT images—particularly for VAT, where the abdominal viscera may cause a single slice to misrepresent true adipose tissue volume. We also lacked data on tissue-level LPL activity and circulating leptin and adiponectin levels, and thus were unable to investigate their influence on our findings. Finally, all correlative observations should be interpreted with some caution, and are not meant to imply causation. The current findings should be validated in larger, independent samples. Conclusions In conclusion, we observed that in men, but not women, aerobic exercise-induced loss of thigh intermuscular adipose tissue was associated with increases in LDL and HDL particle sizes, both of which represent improvements in atherogenic dyslipidemia. In multivariable models, IMAT change, but not visceral adipose tissue change, was associated with both HDL and LDL size change. These data suggest that in overweight, dyslipidemic men, thigh intermuscular adipose tissue may be mechanistically involved in exercise-induced improvements in atherogenic dyslipidemia. This provides evidence that aerobic exercise confers local, peripheral metabolic benefits that are likely to be additive with more centrally-oriented dietary or pharmacologic mechanisms of reducing cardiovascular disease risk.
17 ACKNOWLEDGEMENTS We thank Dr. Kim Huffman for her help with statistical analysis. Preliminary findings included in this analysis were first presented in abstract form at the 2008 American Diabetes Association Scientific Sessions, San Francisco, CA. Ms. Mabe’s current affiliation: Division of NeuroOncology, Department of Surgery, Duke University Medical Center, Durham, NC. GRANTS This work was supported by NHLBI (NIH) grant number R01HL-57354 (Kraus, PI). Mr. Durheim was supported by NIH grant number TL1 RR024126. DISCLOSURES The authors have no conflicts of interest to disclose.
18 REFERENCES 1. Albu JB, Kovera AJ, Allen L, Wainwright M, Berk E, Raja-Khan N, Janumala I, Burkey B, Heshka S, and Gallagher D. Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women. Am J Clin Nutr 82: 12101217, 2005. 2. Cheung MC, Brown BG, Wolf AC, and Albers JJ. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 32: 383-394, 1991. 3. Despres JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, and Bouchard C. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol 20: 1932-1938, 2000. 4. Despres JP, Gagnon J, Bergeron J, Couillard C, Leon AS, Rao DC, Skinner JS, Wilmore JH, and Bouchard C. Plasma post-heparin lipase activities in the HERITAGE Family Study: the reproducibility, gender differences, and associations with lipoprotein levels. HEalth, RIsk factors, exercise Training and GEnetics. Clin Biochem 32: 157-165, 1999. 5. Gallagher D, Kuznia P, Heshka S, Albu J, Heymsfield SB, Goodpaster B, Visser M, and Harris TB. Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr 81: 903-910, 2005. 6. Garenc C, Perusse L, Bergeron J, Gagnon J, Chagnon YC, Borecki IB, Leon AS, Skinner JS, Wilmore JH, Rao DC, and Bouchard C. Evidence of LPL gene-exercise interaction for body fat and LPL activity: the HERITAGE Family Study. J Appl Physiol 91: 1334-1340, 2001. 7. Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, Nevitt M, Holvoet P, and Newman AB. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 165: 777-783, 2005. 8. Goodpaster BH, Krishnaswami S, Resnick H, Kelley DE, Haggerty C, Harris TB, Schwartz AV, Kritchevsky S, and Newman AB. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26: 372-379, 2003. 9. Goodpaster BH, Thaete FL, and Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 71: 885-892, 2000. 10. Halverstadt A, Phares DA, Wilund KR, Goldberg AP, and Hagberg JM. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metabolism 56: 444-450, 2007. 11. Heilbronn L, Smith SR, and Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 28 Suppl 4: S12-21, 2004.
19 12. Houmard JA, Tanner CJ, Slentz CA, Duscha BD, McCartney JS, and Kraus WE. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol 96: 101-106, 2004. 13. Janssen I, Fortier A, Hudson R, and Ross R. Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 25: 431-438, 2002. 14. Kiens B, Roepstorff C, Glatz JF, Bonen A, Schjerling P, Knudsen J, and Nielsen JN. Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender. J Appl Physiol 97: 1209-1218, 2004. 15. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, and Slentz CA. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347: 1483-1492, 2002. 16. Kraus WE, Torgan CE, Duscha BD, Norris J, Brown SA, Cobb FR, Bales CW, Annex BH, Samsa GP, Houmard JA, and Slentz CA. Studies of a targeted risk reduction intervention through defined exercise (STRRIDE). Med Sci Sports Exerc 33: 1774-1784, 2001. 17. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, and Despres JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95: 69-75, 1997. 18. Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, and Ross R. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 284: E1065-1071, 2003. 19. Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH, and Kahn SE. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 52: 172-179, 2003. 20. Ohira M, Miyashita Y, Ebisuno M, Saiki A, Endo K, Koide N, Oyama T, Murano T, Watanabe H, and Shirai K. Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients. Diabetes Res Clin Pract 78: 34-41, 2007. 21. Otvos JD, Jeyarajah EJ, and Bennett DW. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 37: 377-386, 1991. 22. Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C, Bergeron J, Lamarche B, and Despres JP. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 42: 2007-2014, 2001. 23. Perreault L, Lavely JM, Kittelson JM, and Horton TJ. Gender differences in lipoprotein lipase activity after acute exercise. Obes Res 12: 241-249, 2004. 24. Pond CM, Mattacks CA, and Sadler D. The effects of exercise and feeding on the activity of lipoprotein lipase in nine different adipose depots of guinea pigs. Int J Biochem 24: 1825-1831, 1992. 25. Rainwater DL, Mitchell BD, Comuzzie AG, and Haffner SM. Relationship of lowdensity lipoprotein particle size and measures of adiposity. Int J Obes Relat Metab Disord 23: 180-189, 1999.
20 26. Rip J, Nierman MC, Wareham NJ, Luben R, Bingham SA, Day NE, van Miert JN, Hutten BA, Kastelein JJ, Kuivenhoven JA, Khaw KT, and Boekholdt SM. Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPICNorfolk prospective population study. Arterioscler Thromb Vasc Biol 26: 637-642, 2006. 27. Seip RL, Angelopoulos TJ, and Semenkovich CF. Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue. Am J Physiol 268: E229-236, 1995. 28. Seip RL, Mair K, Cole TG, and Semenkovich CF. Induction of human skeletal muscle lipoprotein lipase gene expression by short-term exercise is transient. Am J Physiol 272: E255-261, 1997. 29. Slentz CA, Aiken LB, Houmard JA, Bales CW, Johnson JL, Tanner CJ, Duscha BD, and Kraus WE. Inactivity, exercise, and visceral fat. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol 99: 1613-1618, 2005. 30. Sunayama S, Watanabe Y, Ohmura H, Sawano M, Shimada K, Mokuno H, Daida H, and Yamaguchi H. Effects of troglitazone on atherogenic lipoprotein phenotype in coronary patients with insulin resistance. Atherosclerosis 146: 187-193, 1999. 31. Tall AR. Exercise to reduce cardiovascular risk--how much is enough? N Engl J Med 347: 1522-1524, 2002. 32. Thompson PD, Tsongalis GJ, Seip RL, Bilbie C, Miles M, Zoeller R, Visich P, Gordon P, Angelopoulos TJ, Pescatello L, Bausserman L, and Moyna N. Apolipoprotein E genotype and changes in serum lipids and maximal oxygen uptake with exercise training. Metabolism 53: 193-202, 2004. 33. Thompson PD, Yurgalevitch SM, Flynn MM, Zmuda JM, Spannaus-Martin D, Saritelli A, Bausserman L, and Herbert PN. Effect of prolonged exercise training without weight loss on high-density lipoprotein metabolism in overweight men. Metabolism 46: 217223, 1997. 34. Vakkilainen J, Makimattila S, Seppala-Lindroos A, Vehkavaara S, Lahdenpera S, Groop PH, Taskinen MR, and Yki-Jarvinen H. Endothelial dysfunction in men with small LDL particles. Circulation 102: 716-721, 2000. 35. Willis LH, Slentz CA, Houmard JA, Johnson JL, Duscha BD, Aiken LB, and Kraus WE. Minimal versus umbilical waist circumference measures as indicators of cardiovascular disease risk. Obesity (Silver Spring) 15: 753-759, 2007. 36. Yim JE, Heshka S, Albu J, Heymsfield S, Kuznia P, Harris T, and Gallagher D. Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. Int J Obes (Lond) 31: 1400-1405, 2007.
21 FIGURE LEGENDS Figure 1: Relationships between Intermuscular Adipose Tissue (IMAT) change and lipoprotein particle size changes in men. Pearson correlations were performed for men (n = 40) and women (n = 33, not shown). Note: Y-axis scales differ between panels. A. HDL size change B. LDL size change
TABLE LEGENDS Table 1. Subject characteristics. Values given as mean ± S.D. and frequency (%). Baseline SI given as geometric mean ± geometric S.D. as distribution was not normal. Percentages may not total 100% due to rounding. BMI, body mass index; IMAT, intermuscular adipose tissue; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue, SI, Insulin Sensitivity Index derived from intravenous glucose tolerance test with minimal model analysis (12). Adherence was calculated as the number of minutes of exercise at the appropriate intensity divided by the prescribed number of minutes. Proportions of self-identified race and exercise group by gender were compared using χ2 tests of association. Significance of within- and between-gender differences was otherwise assessed with two-tailed t tests. *Significant gender difference at P < 0.05. †Significant within-gender change with training at P < 0.05.
Table 2. Regression coefficients for gender-IMAT change model. n = 73 (40 men, 33 women). Generated by general linear modeling without selection. ΔIMAT, intermuscular adipose tissue change.
22
Table 3. Regression coefficients and type III sums of squares for IMAT change-VAT change model: men only. n = 40. Generated by general linear modeling without selection. ΔIMAT, intermuscular adipose tissue change; ΔVAT, visceral adipose tissue change.
Table 1. Subject Characteristics.
Women (n = 33)
Men (n = 40)
Variable
Baseline
Change
Baseline
Change
Age (years)
54.0 ± 5.6
-
50.9 ± 6.4*
-
Caucasian
27 (82)
-
33 (83)
-
African-American
5 (15)
-
5 (13)
-
Other
1 (3)
-
2 (5)
-
Body mass (kg)
77.2 ± 10.6
-0.8 ± 2.5
94.4 ± 10.8*
-2.4 ± 2.5*†
BMI (kg/m2)
29.8 ± 2.8
-0.3 ± 1.0†
30.4 ± 2.5
-0.8 ± 0.8*†
Low amount/moderate intensity
10 (30)
-
8 (20)
-
Low amount/vigorous intensity
13 (39)
-
16 (40)
-
High amount/high intensity
10 (30)
-
16 (40)
-
Adherence (%)
90.8 ± 10.4
-
89.9 ± 11.0
-
Relative peak VO2 (mL/kg/min)
23.9 ± 3.6
2.3 ± 1.9†
32.8 ± 3.8*
4.4 ± 3.4*†
HDL (mg/dL)
60.7 ± 15.5
0.4 ± 6.4
40.8 ± 9.4*
1.9 ± 5.2†
LDL (mg/dL)
129.5 ± 22.2
0.0 ± 14.1
119.4 ± 20.2*
-0.2 ± 18.9
HDL size (nm)
9.14 ± 0.37
-0.01 ± 0.11
8.74 ± 0.22*
0.02 ± 0.19
LDL size (nm)
21.25 ± 0.63
0.00 ± 0.37
20.45 ± 0.70*
0.13 ± 0.42
Triglyceride (mg/dL)
130.9 ± 71.6
-9.5 ± 54.2
156.4 ± 67.7
-21.1 ± 55.8†
Thigh IMAT (cm2)
9.77 ± 4.45
-0.55 ± 1.34†
7.55 ± 3.25*
-0.55 ± 1.28†
124.71 ± 34.84
-5.59 ± 11.49†
65.82 ± 18.10*
-3.96 ± 7.53†
Race
Exercise group
Thigh SAT (cm2)
VAT (cm2)
*
141.60 ± 60.12
-2.71 ± 27.93
204.89 ± 60.93*
-23.3 ± 34.68*†
Fasting Glucose (mg/dL)
95.0 ± 11.7
0.2 ± 8.4
95.4 ± 8.3
-0.3 ± 8.5
Fasting Insulin (μU/mL)
8.3 ± 4.7
-1.6 ± 2.9†
11.4 ± 9.3
-1.6 ± 5.1
SI (mU·L-1·min-1)
3.8 ± 1.8
0.9 ± 2.8
2.5 ± 1.9*
1.2 ± 1.4†
Significant gender difference at P < 0.05. †Significant within-gender change with training at P < 0.05.
Figure 1. Relationships between Intermuscular Adipose Tissue (IMAT) change and lipoprotein particle size changes in men.
HDL particle size change (nm)
0.6
A 0.4
0.2
0
r = -0.423 p = 0.0065
-0.2
-0.4
LDL particle size change (nm)
1.25
B 0.75
0.25
-0.25
r = -0.521 p = 0.0006
-0.75
-1.25 -6
-5
-4
-3
-2
-1
0
1
2 2
Intermuscular adipose tissue change (cm )
Table 2. Regression coefficients for gender-IMAT change model. Δ HDL particle size (nm) β Full Model
P 0.0120
Model R2
Δ LDL particle size (nm) β
0.1458
P 0.0022
Δ IMAT (cm2)
-0.063
0.0310
-0.171
0.0154
(female) gender
0.007
0.8671
0.036
0.7012
Δ IMAT*gender
0.065
0.0200
0.175
0.0108
Model R2 0.1892
Table 3. Regression coefficients and type III sums of squares for IMAT change-VAT change model: men only. Δ HDL particle size (nm) β
P
Sum of
Model R2
Δ LDL particle size (nm) β
P
Squares Full Model
0.0096
0.310
Sum of
Model R2
Squares 0.2220
0.0012
2.079
Δ IMAT (cm2)
-0.0508
0.0343
0.142
-0.1472
0.0042
1.192
Δ VAT (cm2)
-0.0012
0.1618
0.060
0.0024
0.1889
0.229
0.3055
